Professor Philip Sloan Anna Long Dr Max Robinson
| Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma: The PREDICTR-OPC Study | 2024 |
|
Professor Philip Sloan
| Understanding interobserver variability of pathologists to improve oral epithelial dysplasia grading | 2024 |
|
Dr Tom Ewen Stuart Horswell Dr Helen Bosomworth Joe Lowenstein Grant Richardson et al. | Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma | 2024 |
|
Professor Gareth Veal Professor Steve Wedge Dr Christopher Bacon Professor Philip Sloan Professor Alastair Greystoke et al. | A phase I dose-escalation study of AZD3965, an oral monocarboxylate transporter 1 inhibitor, in patients with advanced cancer | 2023 |
|
Professor Philip Sloan
| Sinonasal Amoebiasis: An Unexpected Cause of Sinonasal Necroinflammatory Disease | 2023 |
|
Dr Hans Sathasivam Professor Philip Sloan Professor Peter Thomson Dr Max Robinson
| The clinical utility of contemporary oral epithelial dysplasia grading systems | 2022 |
|
Professor Philip Sloan
| Malignant transformation of calcifying epithelial odontogenic tumour with solitary pulmonary metastasis | 2021 |
|
Dr Beate Haugk Professor Kofi Oppong Professor John Leeds Dr Antony Darne Professor Philip Sloan et al. | Morphological and p40 immunohistochemical analysis of squamous differentiation in endoscopic ultrasound guided fine needle biopsies of pancreatic ductal adenocarcinoma | 2021 |
|
Professor Philip Sloan
| Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer | 2021 |
|
Dr Hans Sathasivam Dr Ralf Kist Professor Philip Sloan Professor Peter Thomson Michael Nugent et al. | Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology | 2021 |
|
Dr Hans Sathasivam Professor Philip Sloan Professor Peter Thomson
| Dysplasia and DNA ploidy to prognosticate clinical outcome in oral potentially malignant disorders | 2020 |
|
Dr Hans Sathasivam John Casement Professor Philip Sloan Dr Max Robinson Dr Ralf Kist et al. | Gene expression changes associated with malignant transformation of oral potentially malignant disorders | 2020 |
|
Professor Philip Sloan
| Data set for the reporting of nodal excisions and neck dissection specimens for head and neck tumors explanations and recommendations of the guidelines from the international collaboration on Cancer reporting | 2019 |
|
Professor Philip Sloan
| Data set for the reporting of oral cavity carcinomas explanations and recommendations of the guidelines from the international collaboration of Cancer reporting | 2019 |
|
Dr Hans Sathasivam Professor Philip Sloan Dr Ralf Kist Dr Max Robinson
| Prognostic Classifier for Oral Potentially Malignant Disorders: An Integrated Histopathological and Molecular approach | 2019 |
|
Dr Max Robinson Professor Philip Sloan
| The use of digital pathology and image analysis in clinical trials | 2019 |
|
Dr Max Robinson Professor Philip Sloan Dr Andrew Hall
| Training and accreditation standards for pathologists undertaking clinical trial work | 2019 |
|
Dr Louise Johnston Dr Michael Power Professor Philip Sloan Anna Long Dr Angela Silmon et al. | Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue | 2018 |
|
Dr Hans Sathasivam Benjamin Cosway Professor Vinidh Paleri Matt Kennedy Dr Rachel Pearson et al. | Clinicopathological features of squamous cell carcinoma of the oral cavity and oropharynx in young patients | 2018 |
|
Dr Hans Sathasivam Paula Bradley Professor Vinidh Paleri Professor Philip Sloan Dr Max Robinson et al. | Concurrent HPV-related oropharyngeal carcinoma in four couples | 2018 |
|
Professor Philip Sloan
| Evaluation of an innovative oral brush for potential applications using liquid based cytology | 2018 |
|
Dr Timothy Bates Dr Michaela Goodson Professor Peter Thomson Professor Philip Sloan Dr Ralf Kist et al. | Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis | 2016 |
|
Dr Max Robinson Professor Philip Sloan
| HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology | 2016 |
|
Dr Max Robinson Professor Philip Sloan
| Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines | 2016 |
|
Professor Philip Sloan Professor Muzlifah Haniffa
| Rosai-Dorfman disease: successful treatment with methotrexate | 2016 |
|
Professor Philip Sloan
| Sentinel Node in Oral Cancer The Nuclear Medicine Aspects. A Survey from the Sentinel European Node Trial | 2016 |
|
Dr Michaela Goodson Professor Philip Sloan Dr Max Robinson Professor Peter Thomson
| Oral precursor lesions and malignant transformation - who, where, what, and when? | 2015 |
|
Professor Philip Sloan Professor Marco Carrozzo
| Oral purpura as the first manifestation of primary systemic amyloidosis | 2015 |
|
Professor Philip Sloan
| Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer | 2015 |
|
Dr Anne Chambers Dr Max Robinson Robert Banks Professor Philip Sloan
| Twenty-first-century oral hairy leukoplakia-a non-HIV-associated entity | 2015 |
|
Professor Peter Thomson Professor Philip Sloan
| Diagnostic adjunctive techniques and the management of oral potentially malignant disorders | 2014 |
|
Dr Timothy Bates Professor Peter Thomson Professor Philip Sloan Dr Max Robinson Dr Ralf Kist et al. | PAX9 expression in potentially malignant disorders and early stage squamous carcinoma of the oral cavity | 2014 |
|
Professor Philip Sloan Dr Max Robinson
| Squamous Cell Carcinoma of the Head and Neck Outside the Oropharynx Is Rarely Human Papillomavirus Related | 2014 |
|
Dr Timothy Bates Professor Philip Sloan
| Unicystic Ameloblastoma Presenting in Gardner's Syndrome | 2014 |
|
Dr Ameena Diajil Dr Max Robinson Professor Philip Sloan Professor Peter Thomson
| Clinical Outcome Following Oral Potentially Malignant Disorder Treatment: A 100 Patient Cohort Study | 2013 |
|
Professor Philip Sloan
| Dilemmas of Oral Cancer Screening: An Update | 2013 |
|
Professor Philip Sloan Professor Peter Thomson
| Interobserver agreement for Velscope grading of normal and pathological oral mucosa | 2013 |
|
Professor Philip Sloan Dr Max Robinson
| Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma | 2013 |
|
Dr Timothy Bates Dr Tuomo Polvikoski Professor Philip Sloan Dr David Meikle Dr Max Robinson et al. | Ganglioneuroblastic transformation in olfactory neuroblastoma | 2012 |
|
Dr Max Robinson Professor Philip Sloan
| HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients | 2012 |
|
Professor Peter Thomson Professor Philip Sloan
| Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study | 2012 |
|
Professor Philip Sloan
| The Expression of FHIT in Salivary Carcinoma Ex Pleomorphic Adenoma | 2012 |
|
Dr Edmund Ong Professor Philip Sloan Dr Konrad Staines
| Three cases of oral syphilis - an overview | 2012 |
|
Professor Philip Sloan Dr Max Robinson
| Validation for a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. | 2012 |
|
Dr Michaela Goodson Professor Peter Thomson Professor Philip Sloan
| Accuracy and patient acceptance of brush cytology for diagnosis of potentially malignant lesions and oral cancer | 2011 |
|
Dr Max Robinson Professor Philip Sloan
| Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity and prognostic discrimination | 2011 |
|
Professor Philip Sloan Dr Max Robinson
| Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice | 2011 |
|
Dr Christine Challen Professor Philip Sloan Professor Mark Birch-Machin Dr Max Robinson
| Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility | 2011 |
|
Professor Philip Sloan Dr Gavin Spickett Dr Konrad Staines
| Oral hairy leukoplakia in a patient on long-term anticonvulsant treatment with lamotrigine | 2011 |
|
Dr Konrad Staines Professor Philip Sloan
| Syphilitic Chancre of the Tongue | 2011 |
|
Dr Max Robinson Professor Philip Sloan
| CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions | 2010 |
|
Professor Vinidh Paleri Dr Konrad Staines Professor Philip Sloan Emerita Professor Janet Wilson
| Evaluation of oral ulceration in primary care | 2010 |
|
Professor Philip Sloan
| Healing of tooth extraction sockets in the streptozotocin diabetic rat model: Induction of cartilage by BMP-6 | 2010 |
|
Professor Philip Sloan
| Immunohistochemical expression of estrogens and progesterone receptors in carcinoma ex pleomorphic adenoma-undifferentiated and adenocarcinoma types | 2010 |
|
Dr Max Robinson Professor Philip Sloan
| Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing | 2010 |
|
Dr Michaela Goodson Professor Philip Sloan Professor Peter Thomson
| Tissue autofluorescence techniques and the early diagnosis of mouth cancer | 2010 |
|
Professor Philip Sloan
| Head and neck sentinel lymph node biopsy: current state of the art | 2009 |
|
Professor Philip Sloan
| Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma | 2009 |
|
Professor Philip Sloan
| Joint Practice Guidelines for Radionuclide Lymphoscintigraphy for Sentinel Node Localization in Oral/Oropharyngeal Squamous Cell Carcinoma | 2009 |
|
Professor Philip Sloan
| Fixed drug eruption to oxybutynin | 2008 |
|
Professor Philip Sloan
| Relation of a Hypoxia Metagene Derived from Head and Neck Cancer to Prognosis of Multiple Cancers | 2007 |
|
Dr Laura Hampson Professor Philip Sloan
| Tumor Epression of Major Vault Protein is an Adverse Prognostic Factor for Radiotherapy Outcome in Oropharyngeal Carcinoma | 2007 |
|
Professor Philip Sloan
| Fragile Histidine Triad Expression in Oral Squamous Cell Carcinoma and Precursor Lesions | 2006 |
|
Professor Philip Sloan
| Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection: results of EORTC Translational Research Fund studies | 2004 |
|
Professor Philip Sloan Kersi Fanibunda Professor Stephen Proctor
| Polymorphic reticulosis with oral lesions: A case report | 1986 |
|